Prior metabolic surgery attenuates the weight-loss efficacy of liraglutide in patients with mild obesity
A history of MS significantly affects liraglutide's responsiveness in patients with mild obesity, emphasizing the need for personalized therapeutic strategies in post-surgical patients. These findings highlight the importance of a comprehensive medical history in guiding obesity pharmacotherapy.
Authors
- Xuehui Chu
- Yifei Ouyang (ORCID: https://orcid.org/0000-0002-9092-8165)
- Wenjuan Tang (ORCID: https://orcid.org/0009-0001-7984-5254)
- Xinyue Xiang
- Wenhuan Feng
- Xinyun Hu
Institutions
- Nanjing University of Chinese Medicine (CN)
- National Clinical Research Center for Digestive Diseases (CN)
- Nanjing Drum Tower Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-05-22
- DOI
- https://doi.org/10.3389/fendo.2025.1580159
- Primary Topic
- Pharmacology and Obesity Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Government of Jiangsu Province
- Natural Science Foundation of Jiangsu Province
- National Science and Technology Major Project
- National Key Research and Development Program of China